SP600125

目录号:S1460 别名: Nsc75890

SP600125 Chemical Structure

Molecular Weight(MW): 220.23

SP600125是一种广谱JNK抑制剂,作用于JNK1,JNK2和JNK3,无细胞试验中IC50分别为40 nM,40 nM和90 nM,比作用于MKK4选择性高10倍,比作用于MKK3, MKK6, PKB,和PKCα选择性高25倍,比作用于ERK2, p38, Chk1, EGFR等选择性高100倍。

规格 价格 库存 购买数量  
RMB 1554.71 现货
RMB 633.17 现货
RMB 2011.01 现货
RMB 4814.33 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck该产品发表文献52篇:

客户使用该产品的6个实验数据:

  • Western blotting analysis of total cell lysates from liver of Ulk1/2 Ctrl and LDKO mice treated or untreated with JNK inhibitor SP00125 (10 mg/kg) or APAP for 6 h.

    Hepatology, 2018, 67(6):2397-2413. SP600125 purchased from Selleck.

    Loss of DUSP4 function upregulates IL-6 and IL-8 and enhances mammosphere growth. Immunoblot analysis of MDA-231 cells after treatment of 24 hours with 1 umol/L selumetinib (MEKi) or 10 umol/L SP600125 (JNKi). I, MDA-231 mammosphere formation quantitated by GelCount software 7 days after siRNA transfection. Where indicated, selumetinib (MEKi) or SP600125 (JNK1) or the combination was added to the mammosphere cultures.

    Cancer Res 2013 73(20):6346-58. SP600125 purchased from Selleck.

  • DEM stimulates JNK. HepG2 cells were incubated in the presence of 10 µM SP600125 (or DMSO as solvent control) for 1 h, followed by exposure to DEM at the given concentration for 1 h in the continued presence of SP600125 (or solvent control). Cells were lysed and subjected to SDS-PAGE and Western analysis of JNK and cJun phosphorylation. The blots shown are representative of two independent experiments.

    Redox Biol, 2018, 20:19-27. SP600125 purchased from Selleck.

    Comparative effects of inhibitors by immunofluorescence microscopy study. Confluent HC11 cells were grown on poly-L-lysine-coated glass coverslips (immunofluorescence) and on plastic plates (biochemical control) and then treated with inhibitors according to the standard procedure. Upper part: the biochemical action of the inhibitors was tested to validate the immunofluorescence results. Cellular proteins were analyzed by SDS-PAGE and the immunoblots were successively probed with anti-ADRP, anti-β-casein, and anti- β-actin antibodies and their respective HRP-conjugated secondary antibodies. Each experimental condition was performed in duplicate. Lower part: cells were fixed, permeabilized and subjected to immunofluorescence microscopy using antiserum against ADRP and TRITC-conjugated secondary antibody (red).

    Biochim Biophys Acta 2012 1823(5), 987-96. SP600125 purchased from Selleck.

  • Bone marrow derived macrophages were pre-treated with the indicated concentrations of SP600125 for 1h prior to LPS treatment (100 ng/ml).  TNF-a production was analyzed 24h later.

    Lee lay hoon from National University of Singapore. SP600125 purchased from Selleck.

    SP600125 purchased from Selleck.

产品安全说明书

JNK抑制剂选择性比较

生物活性

产品描述 SP600125是一种广谱JNK抑制剂,作用于JNK1,JNK2和JNK3,无细胞试验中IC50分别为40 nM,40 nM和90 nM,比作用于MKK4选择性高10倍,比作用于MKK3, MKK6, PKB,和PKCα选择性高25倍,比作用于ERK2, p38, Chk1, EGFR等选择性高100倍。
特性 SP600125是丝/苏氨酸激酶广谱抑制剂,有效抑制c-Jun 氨基末端激酶(JNK)。
靶点
JNK1 [1]
(Cell-free assay)
JNK2 [1]
(Cell-free assay)
Aurora A [4]
(Cell-free assay)
TrkA [4]
(Cell-free assay)
JNK3 [1]
(Cell-free assay)
40 nM 40 nM 60 nM 70 nM 90 nM
体外研究

SP600125是ATP竞争性的c-Jun氨基末端激酶(JNK)选择性抑制剂,IC50为40 nM 到90 nM。SP600125作用于Jurkat T细胞,抑制c-Jun磷酸化,IC50为5 μM 到10 μM。SP600125作用于CD4+细胞, 如从人脐血或外周血分离的Th0细胞,抑制细胞活化和分化,且抑制炎症基因 COX-2, IL-2, IL-10, IFN-γ,和TNF-α的表达, IC50为5 μM 到 12 μM。[1]然而,后期研究显示 SP600125 也抑制香烃受体(AhR)[2] Mps1,[3] 和一系列其他丝/苏氨酸激酶, 包括Aurora 激酶 A, FLT3, MELK,和 TRKA。[4] 20 μM SP600125作用于小鼠beta 细胞 MIN6, 诱导p38 MAPK 磷酸化,和其下游CREB依赖的 启动子的激活。[5] 20 μM SP600125 作用于HCT116细胞, 使有丝分裂停在G2期,且诱导核内复制。[6]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Plasmodium falciparum HB3 Mlv4RY51cWKjY4TldolidCCDc4PhfS=> MXy3NkBp M2r4dmROW09? Mn\hRY51cXCuYYPtc4Rq[WxiYXP0bZZqfHlid3n0bEBKSzVyIH;mJFcvQTR|Mkig{txO MnzrNVk4OzR7MUC=
Plasmodium falciparum W2 NFr4dZZCdnSrYnHjeIVzcWGuIFHzd4F6 NGHHTGY4OiCq NVT3VItzTE2VTx?= MnPaRY51cXCuYYPtc4Rq[WxiYXP0bZZqfHlid3n0bEBKSzVyIH;mJFcvQTR|Mkig{txO MUGxPVc{PDlzMB?=
Plasmodium falciparum 7G8 NHO5do9CdnSrYnHjeIVzcWGuIFHzd4F6 NXOzT2RbPzJiaB?= MkPwSG1UVw>? NH\J[ZZCdnSrcHzhd41w\GmjbDDhZ5Rqfmm2eTD3bZRpKEmFNUCgc4YhOTBizszN NY\WPJVKOTl5M{S5NVA>
Plasmodium falciparum 3D7 NFri[4VCdnSrYnHjeIVzcWGuIFHzd4F6 M3T3VlczKGh? NYHZc494TE2VTx?= NVS2b|kzSW62aYDsZZNud2SrYXygZYN1cX[rdImge4l1cCCLQ{WwJI9nKDF{LkW4PVMh|ryP MkW3NVk4OzR7MUC=
Plasmodium falciparum GB4 MWTBcpRq[mGldHXybYFtKEG|c3H5 MUO3NkBp MUTEUXNQ NEjzSIxCdnSrcHzhd41w\GmjbDDhZ5Rqfmm2eTD3bZRpKEmFNUCgc4YhOTJwNUi5N:69VQ>? M{fqeFE6PzN2OUGw
RAW264.7 NYm0VHRKTnWwY4Tpc44hSXO|YYm= M4jyd|ExKM7:TR?= MnzjNVIhcA>? Moi2RY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFzQV{1qdmS3Y3XkJG5QKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFE4|ryP M3PQZVE6PDl5NEG4
SH-SY5Y NF[wdmRHfW6ldHnvckBCe3OjeR?= M1HnNFExKM7:TR?= NXTqWZgyOSCq NGfxSnVFVVOR NXHJbllqVmW3cn;wdo91\WO2aY\lJIFkfGm4aYT5JIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDhcol{d227Y3nuMYlv\HWlZXSgZ4VtdCCmZXH0bC=> NV[2TIxlOjN2OUi5NVQ>
SH-SY5Y NVnreWlVU2mwYYPlJGF{e2G7 MonpNVAh|ryP NHTSOFAyKGh? NYfsTXBDTE2VTx?= MYPJcohq[mm2aX;uJI9nKEqQS{OgZZN{\XO|ZXSgZZMh[myxY3vh[IUhd2ZiYX7pd49ugWOrbj3pcoR2[2WmIHOtbpVvKHCqb4PwbI9zgWyjdHnvckBifCC|ZYK3Ny=> Mnz1NlM1QTh7MUS=
RAW264.7 NV;ydocyTnWwY4Tpc44hSXO|YYm= MojUNVAh|ryP MUGyOEBp MWjBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiSVytNYJmfGFicnXs[YF{\Q>? NXnLb|hoOjN5OUGwO|g>
RAW264.7 NVjNT2F1TnWwY4Tpc44hSXO|YYm= NIXidpcyOCEQvF2= MYKyOEBp NGTMfYRCdnSraX7mcIFudWG2b4L5JIFkfGm4aYT5JIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gUHBUNWmwZIXj[YQhcU6RUzDlfJBz\XO|aX;u NUS2cpo2OjN5OUGwO|g>
RAW264.7 NYXNW3pLTnWwY4Tpc44hSXO|YYm= MWexNEDPxE1? NUnOOZRSOiCq MljXRY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFzQV{1qdmS3Y3XkJG5QKHC{b3T1Z5Rqd25? NIKx[3QzOzd7MUC3PC=>
B16-F10 MYHGeY5kfGmxbjDBd5NigQ>? NYLSTohpOSCq NIDiSYpKdmirYnn0bY9vKG:oIGTOSk1idHCqYT3pcoR2[2WmIHOtTnVPKHCqb4PwbI9zgWyjdHnvci=> NYq0UIFYOjF6MUW2N|Q>
PC12 NFjLN5RHfW6ldHnvckBCe3OjeR?= M{jDRlExKM7:TR?= MWC1JIg> M{nke2ROW09? NWn5dHJISWO2aY\heIlwdiCxZjDOdoYzN0GURTDhd5Nme3OnZDDhd{BJVy1zIIDyc5RmcW5iaX7keYN1cW:wIIDy[ZRz\WG2ZXSge4l1cCCSREm4NFU6 NWXoOG5xOjF|NEW2PFU>
PC12 MlHoSpVv[3Srb36gRZN{[Xl? MVWxNEDPxE1? MkHaOUBp MXjEUXNQ MWLBZ5RqfmG2aX;uJI9nKE6{ZkKvRXJGKGG|c3Xzd4VlKGG|IFjPMVEheHKxdHXpckBqdmS3Y4Tpc44heHKndILlZZRm\CC5aYToJHUxOTJ4 NISweWozOTN2NU[4OS=>
PC12 MYDGeY5kfGmxbjDBd5NigQ>? MnrDNVAh|ryP M1TxdlUhcA>? Mm\FSG1UVw>? NH:0VJlC[3SrdnH0bY9vKG:oIF7y[lIwSVKHIHHzd4V{e2WmIHHzJGhQNTFicILveIVqdiCrbnT1Z5Rqd25icILleJJm[XSnZDD3bZRpKFOSNkCwNVI2 MXyyNVM1PTZ6NR?=
PC12 NUmyeFBsTnWwY4Tpc44hSXO|YYm= MUWxNEDPxE1? MUK1JIg> NFvwPZlFVVOR NUDYR2JKSWO2aY\heIlwdiCxZjDOdoYzN0GURTDhd5Nme3OnZDDhd{BJVy1zIIDyc5RmcW5iaX7keYN1cW:wIIDy[ZRz\WG2ZXSge4l1cCCVQkKwN|U5OA>? MYmyNVM1PTZ6NR?=
A549 Ml\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHoNlAh|ryP NXK2eHVDPzJiaB?= NH;YVXdFVVOR M4rTZ3JieGmmIHHu[EBxd3SnboSgbY5pcWKrdHnvckBw\iClZXzsJJBzd2yrZnXyZZRqd25? NHHR[pQzOzlzMki0NC=>
PC3 MlrqSpVv[3Srb36gRZN{[Xl? NUTsSHYzOjVizszN MlrSNlQhcA>? NFPnbIpKdmirYnn0bY9vKG:oIFHQMVEh[W6mIICyNUBtfWOrZnXyZZNmKGGldHn2bZR6KGmwZIXj[YQh[nliU{G3PWQhWFKO M3\yTFI{OTZ{NkWy
THP-1 Mo\LSpVv[3Srb36gRZN{[Xl? NW\ySnJ3QTBibl2= MkmzN|AhdWmw NF7mWVVKdmirYnn0bY9vKG:oIITpd5N2\SCoYXP0c5Ih\XiycnXzd4lwdg>? MnXrNlI6PDByNUm=
LoVo MVHGeY5kfGmxbjDBd5NigQ>? MUWxJO69VQ>? MUixJIg> MnXMTY5pcWKrdHnvckBw\iCSR1WyMYlv\HWlZXSg[ZhxemW|c3nvckBw\iC3UFGgZY5lKE2PUD25JJNq\26rZnnjZY51dHl? M3\nNVIyQDV7NEe5
LoVo NEDVRXhHfW6ldHnvckBCe3OjeR?= NH3qTWMyKM7:TR?= MVexJIg> NGSyRnFDdG:la4PQS2UzNWmwZIXj[YQh[2WubDDtbYdz[XSrb36gd4lodmmoaXPhcpRtgQ>? MnPXNlE5PTl2N{m=
A549 NV;1cXN2TnWwY4Tpc44hSXO|YYm= NV\SbVNiOjBizszN MXKxJIg> MkHnTY5pcWKrdHnvckBw\iCWUFGtbY5lfWOnZDDNUXAuOiCjbnSgeU1RSSCneIDy[ZN{cW:w MnXWNlA1QTJzN{W=
HaCaT Mn\vSpVv[3Srb36gRZN{[Xl? MonsNlAh|ryP NWP4cJE5PCCq NUfS[415TE2VTx?= MV;CcI9kc3NidHjlJHRPTi4QsT3pcoR2[2WmwrDDXXA1TjFzwrD0doFve2O{aYD0bY9v NGX2U5YyQThzMkO0PS=>
HaCaT NGC4b4VHfW6ldHnvckBCe3OjeR?= NXvUe4I3OjBizszN MYOyOEBp NHnzTnFFVVOR M4HBZ2Jtd2OtczD0bIUheGixc4Doc5J6dGG2aX;uJI9nKGNvSoXuJJBzd3SnaX6= MkfoNVk5OTJ|NEm=
PC3 MoLpSpVv[3Srb36gRZN{[Xl? MXKyNEDPxE1? NYXJO2ZsOSCq NUjBcW5jTGWlcnXhd4V{KHSqZTDNUXAzKGGwZDDNUXA6KGW6cILld5Nqd25? MmrKNVk3OzN7N{W=
BV-2 MnP2SpVv[3Srb36gRZN{[Xl? M1W4fFIh|ryP NIrpc4YyKGh? M3H2ZmlvcGmkaYTzJJRp\SCrbnPy[YF{\SCxZjDzRmFHTiC{ZXzlZZNmKGmwIFftbZgufHKnYYTl[EBDXi1{IHPlcIx{ NFT5Vm8yQTRyNkizNS=>
Hep3B NIe1enBHfW6ldHnvckBCe3OjeR?= NF61UGYyOCEQvF2= MYOxJIg> NWHpb3RtSmyxY3vzJIF2fG:yaHHnfUBidmRidYDy[Yd2dGG2aX;uJI9nKEKnY3zpckAyKGW6cILld5Nqd25iaX7keYNm\CCkeTDj[ZJidWmmZR?= MmjkNVkxPjB7MkC=

... Click to View More Cell Line Experimental Data

体内研究 SP600125按15 mg/kg或30 mg/kg剂量作用于小鼠,显著抑制脂多糖(LPS)诱导的TNF-α表达和CD3抗体诱导的CD4+ CD8+胸腺细胞凋亡。[1]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:[4]
+ 展开

体外激酶实验:

根据测量放射性磷酸转移到底物中的量,而测定SP600125作用于激酶的效果,包括MPS1, JNK, 和 Aurora 激酶 A。使用5 nM MPS1 重组蛋白在50 mM HEPES pH 7.5,2.5 mM MgCl2,1 mM MnCl2,1 mM DTT,3 μM NaVO3, 2 mM β-甘油磷酸,0.2 mg/mL BSA, 200 μM P38-βtide 底物-肽(KRQADEEMTGYVATRWYRAE),和含1.5 nM33P-γ-ATP的8 μM ATP中测量MPS1活性。使用1:3 稀释的(从30 μM 稀释成 1.5 nM) SP600125进行实验,然后测定IC50值。
细胞实验: [4]
+ 展开
  • Cell lines: HCT116, A2780, 和U2OS细胞
  • Concentrations: 0-5 μM, 溶于0.1% DMSO
  • Incubation Time: 72小时
  • Method: 细胞接种在384孔板上。实验第一天,用SP600125处理细胞72小时,然后通过 CellTiter-Glo 实验处理实验板。测定与对照组相比,实验组的抑制活性,计算抑制增殖的IC50值。
    (Only for Reference)
动物实验:[1]
+ 展开
  • Animal Models: 雌性 CD-1小鼠LPS/TNF模型
  • Formulation: 溶于PPCES (30% PEG-400/20% 聚丙二醇/15% Cremophor EL/5% 乙醇/30% 盐水)
  • Dosages: 15或30 mg/kg
  • Administration: 静脉注射或口服处理
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 44 mg/mL (199.79 mM)
Water Insoluble
Ethanol Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
5% DMSO+30% PEG 300+5% Tween 80+ddH2O
3mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 220.23
化学式

C14H8N2O

CAS号 129-56-6
稳定性 powder
in solvent
别名 Nsc75890

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    how to reconstitute the inhibitor for in vivo studies?

  • 回答:

    S1460 can be dissolved in 5% DMSO/corn oil at 5 mg/ml as a clear solution for injection. The inhibitor dissolved in vehicle 30% PEG400/0.5% Tween80/5%Propylene glycol, at 30mg/ml is a suspension and can be used for oral administration.

JNK Signaling Pathway Map

相关JNK产品

Tags: 购买SP600125 | SP600125供应商 | 采购SP600125 | SP600125价格 | SP600125生产 | 订购SP600125 | SP600125代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID